Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Keratosept
- Development stage
- Unknown
- Lead developer
- Visum Pharm
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Keratosept is an ophthalmic solution developed by Visum Pharm, primarily indicated for the protection and repair of the corneal epithelium. The formulation is a combination of three active components: hydroxypropyl methylcellulose (HPMC), cyanocobalamin (Vitamin B12), and chlorhexidine digluconate. HPMC serves as a mucomimetic lubricant that stabilizes the tear film and increases the contact time of the solution with the ocular surface, providing relief from dryness and irritation. Cyanocobalamin supports the metabolic processes of corneal cells, facilitating re-epithelialization and tissue regeneration following injury or surgery. Chlorhexidine digluconate provides a broad-spectrum antiseptic effect, preventing secondary bacterial infections during the healing process. Keratosept is commonly used for corneal abrasions, keratitis, post-operative recovery, and conditions requiring corneal protection and hydration.
- Brand names
- Keratosept
- Other names
- Keratosept-Visum
02
Targets
MMUT (Methylmalonyl-coenzyme A mutase)1C metabolism (One-carbon metabolism)
Beyond the preview
Go deeper on Keratosept.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keratosept.